Blog
e-Projection is going to BIO-Europe® 2021!
e-Projection will be attending the BIO-Europe® 2021! Join us in the virtual space this time, to discuss about your strategy to expand your business globally!! We are a big fan of the Bio conference and really miss the live event. However, the virtual experience went very smoothly and gives a sense of great effectiveness. A […]
e-Projection will deliver a lecture at Tokyo University of Science, Management of Technology
Tokyo University of science, Management of Technology is holding various seminars and Symposiums in order to promote the talent development in the field of management of technology. It is our honor to announce that our CEO, Tosh Nagate will deliver a lecture as a guest speaker there on “Sales forecast for pharmaceutical products and project valuation” . Not only […]
e-Projection is going to Bio Japan in Yokohama
e-Projection is participating in the BioJapan, which is a part of Asia’s largest partnering event. This event is constituted by three exhibitions – 1. The world’s oldest biotechnology exhibition “BioJapan”, 2. “Regenerative Medicine JAPAN”, aiming to accelerate and industrialize R&D in the field of regenerative medicine including iPS cells, and 3.”health TECH JAPAN”, provides fusion […]
Post event report: Online seminar “Update on the valuation of pharmaceuticals in the Covid-19 world”
e-Projection held an online seminar on September 10th, 2021. This seminar titled “Update on the valuation of pharmaceuticals in the Covid-19 world ” brought together more than 100 representatives from Japanese pharmaceutical companies. The speaker this time was our CEO, Toshi Nagate and he spoke about the valuation of development project from comprehensive aspect […]
New Drugs Added to NHI Price List on August 12
The Central Social Insurance Medical Council (Chuikyo), an advisory board for the reimbursement system relating to public healthcare insurance, endorsed the listing of 23 new drugs with 15 ingredients at its general meeting on August 4. These new joined the NHI price list on August 12, including Chugai Pharmaceutical’s Evrysdi (risdiplam), which marks the first […]
To Be, or Not to Be in Japan, That is the Problem
Consider involving Japan in your drug development program, and start thinking about it now Globalization in the pharmaceutical industry is an ongoing and never ending process due to the monotonically increasing desire of people all over the world to gain faster access to healthcare innovation, fueled by the tireless efforts of the drug manufacturers to […]
e-Projection is going to BIO Digital 2021!
We will be attending the BIO Digital 2021! Join us next June 10-11 and 14-17 in the virtual space this time, to discuss about your strategy to expand your business globally!! Now more than ever, the world is counting on us to come together to advance innovation and discovery.
To the last drop
Allowing 7 shots per vial of Pfizer’s covid vaccine may wreak havoc to the already problematic Japanese immunization program Mottainai is one of the virtues of Japanese culture which means avoiding waste and making use of all that is available, especially in a country without significant natural resources. Yesterday, this sense of savings was taken […]
Not going viral enough
MSD’s Silgard 9 silently reaches the market after five years of regulatory turmoil and social aversion against immunization While the covid-19 vaccine is the only thing people talk about, last week another type of jab has been launched in the Japanese market. MSD, a multinational pharmaceutical company which is known as Merck and Co. in […]
e-Projection is going to Biotech Showcase Digital 2021!
Join us in the virtual space this time, to discuss about your strategy to expand your business globally. https://informaconnect.com/biotech-showcase/
